Heretofore, several important immune checkpoint members were supposed to play a key role in tumor‐related immune response, such as PD1, PD‐L1, PD‐L2, CD80, B7‐H3, B7‐H4, TIM‐3, and LAG3.18 This evidence concerns the gene CD276 and neoplasm.